Seikon1
☕ Support

EDGAR Filings (All Forms)

SEC submissions(JSON) 기반으로 모든 Form을 나열합니다. (8-K, F-1, EFFECT 등)

A. Ticker 또는 CIK로 Filings 조회

Tip: ticker만 입력해도 서버에서 CIK로 자동 변환해 조회합니다.
Resolved: AZN → 0000901832 (ASTRAZENECA PLC)
ASTRAZENECA PLC
CIK: 0000901832 • Tickers: AZN
cached: false
FiledFormAccessionPrimary DocSEC IndexSEC DocParse
2026-09-086-K0001654954-26-008172a8764t.htm
IMFINZI+IMDELLTRA IMPROVED OS IN SMALL CELL LUNG
Checking…SEC DocChecking…
2026-09-086-K0001654954-26-008150a5662t.htm
ETCAMAH APPROVED IN THE US FOR HR+ BREAST CANCER
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-008042a7700s.htm
ADMISSION OF FURTHER SECURITIES TO TRADING
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-008040a7697s.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-007992a6788s.htm
ADMISSION TO TRADING - EUR2.55 BILLION BOND OFFERING
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-007990a7351s.htm
ENHERTU APPROVED IN EU FOR 1L HER2-POSITIVE MBC
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-007988a7296s.htm
DIRECTORATE CHANGE
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-007986a7349s.htm
ASTRAZENECA COMPLETES AGREEMENT FOR ZEGFROVY
Checking…SEC DocChecking…
2026-09-016-K0001654954-26-007983a7347s.htm
TAGRISSO + ORPATHYS IMPROVED PFS IN 1L EGFRM LUNG
Checking…SEC DocChecking…
2026-08-276-K0001654954-26-007894a4036s.htm
TEZSPIRE CROSSING TRIAL MET PRIMARY ENDPOINTS
Checking…SEC DocChecking…
2026-08-256-K0001654954-26-007840a9590r.htm
ASTRAZENECA PRICES A EUR2.55 BILLION BOND OFFERING
Checking…SEC DocChecking…
2026-08-196-K0001654954-26-007742a3225r.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-08-176-K0001654954-26-007681a8443q.htm
ENHERTU IMPROVED PFS IN 1L HER2M LUNG CANCER
Checking…SEC DocChecking…
2026-08-176-K0001654954-26-007679a8439q.htm
UPDATE ON EVOLVE-LUNG02 PHASE III TRIAL
Checking…SEC DocChecking…
2026-08-176-K0001654954-26-007677a8441q.htm
TAGRISSO+ORPATHYS IMPROVED PFS & OS IN EGFRM LUNG
Checking…SEC DocChecking…
2026-08-0740002122411-26-000001xslF345X06/primary_doc.xml
PRIMARY DOCUMENT
Checking…SEC DocChecking…
2026-08-036-K0001654954-26-007169a8757o.htm
ADMISSION OF FURTHER SECURITIES TO TRADING
Checking…SEC DocChecking…
2026-08-036-K0001654954-26-007166a8728o.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-07-316-K0001654954-26-007050a7288o.htm
DATROWAY APPROVED IN EU FOR TNBC
Checking…SEC DocChecking…
2026-07-276-K0001104659-26-086846azn-20260630x6k.htm
FORM 6-K
Checking…SEC DocChecking…
2026-07-276-K0001654954-26-006897a8707n.htm
UPDATE ON ULTOMIRIS PHASE III TRIAL IN HSCT-TMA
Checking…SEC DocChecking…
2026-07-276-K0001654954-26-006895a9459n.htm
SONE-VE IMPROVED SURVIVAL IN GASTRIC CANCERS
Checking…SEC DocChecking…
2026-07-236-K0001654954-26-006803a5622n.htm
ETCAMAH APPROVED IN THE EU FOR ER+ BREAST CANCER
Checking…SEC DocChecking…
2026-07-146-K0001654954-26-006637a2449m.htm
ASTRAZENECA LICENSES NOVEL EGFR INHIBITOR
Checking…SEC DocChecking…
2026-07-096-K0001654954-26-006554a6054l.htm
UPDATE ON CARDIO-TTRANSFORM PHASE III TRIAL
Checking…SEC DocChecking…
2026-07-0840001104659-26-081807xslF345X06/tm2619989-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-07-016-K0001654954-26-006430a6348k.htm
ADMISSION OF FURTHER SECURITIES TO TRADING
Checking…SEC DocChecking…
2026-07-016-K0001654954-26-006427a6365k.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-06-2911-K0001683168-26-005159astrazeneca_i11k.htm
FORM 11-K
Checking…SEC DocChecking…
2026-06-296-K0001654954-26-006251a1370k.htm
ENHERTU APPROVED IN EU FOR HER2+ SOLID TUMOURS
Checking…SEC DocChecking…
2026-06-296-K0001654954-26-006239a0148k.htm
DATROWAY RECOMMENDED FOR APPROVAL IN EU FOR TNBC
Checking…SEC DocChecking…
2026-06-1640001104659-26-074570xslF345X06/tm2617978-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-06-156-K0001654954-26-005964a1987i.htm
TRUQAP APPROVED IN US FOR PROSTATE CANCER
Checking…SEC DocChecking…
2026-06-016-K0001654954-26-005587a4701g.htm
ADMISSION OF FURTHER SECURITIES TO TRADING
Checking…SEC DocChecking…
2026-06-016-K0001654954-26-005586a4717g.htm
TOTAL VOTING RIGHTS
Checking…SEC DocChecking…
2026-05-296-K0001654954-26-005498a1377g.htm
IMFINZI APPROVED IN US FOR EARLY BLADDER CANCER
Checking…SEC DocChecking…
2026-05-2825-NSE0000876661-26-000484xslF25X02/primary_doc.xmlChecking…SEC DocChecking…
2026-05-276-K0001654954-26-005381a7798f.htm
US FDA DECISION DATE ON CAMIZESTRANT EXTENDED
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005309a6573f.htm
DATROWAY APPROVED IN US FOR 1L TRIPLE-NEGATIVE BC
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005306a6571f.htm
ENHERTU RECOMMENDED IN EU FOR HER2+ SOLID TUMOURS
Checking…SEC DocChecking…
2026-05-266-K0001654954-26-005303a6568f.htm
CAMIZESTRANT RECOMMENDED FOR BREAST CANCER IN EU
Checking…SEC DocChecking…
2026-05-2240001104659-26-065693xslF345X06/tm2615366-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005049a7391e.htm
DIRECTOR/PDMR SHAREHOLDING
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005044a6161e.htm
BAXFENDY APPROVED IN THE US FOR HYPERTENSION
Checking…SEC DocChecking…
2026-05-186-K0001654954-26-005038a6159e.htm
ENHERTU APPROVED IN TWO HER2+ EARLY BC SETTINGS
Checking…SEC DocChecking…
2026-05-146-K0001654954-26-004836a3223e.htm
IMFINZI + EV IMPROVES EFS & OS IN BLADDER CANCER
Checking…SEC DocChecking…
2026-05-0840001104659-26-057906xslF345X06/tm2614063-1_4seq1.xml
OWNERSHIP DOCUMENT
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004247a8007c.htm
TOTAL VOTING RIGHTS AND ADMISSION OF SHARES
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004229a7028c.htm
FDA ODAC VOTE ON CAMIZESTRANT IN BREAST CANCER
Checking…SEC DocChecking…
2026-05-016-K0001654954-26-004226a7026c.htm
FDA ODAC RECOMMENDS TRUQAP IN PROSTATE CANCER
Checking…SEC DocChecking…
Tip: forms 필터 예) 8-K,10-Q,F-1